Ken Griffin Seer, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Seer, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 200 shares of SEER stock, worth $336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 400 50.0%

Holding current value

$336

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.54 - $2.09 $208,317 - $282,716	135,271 Added 88.42%	288,263 $547,000
Q4 2023 Feb 14, 2024	BUY	$1.47 - $2.22 $187,736 - $283,520	127,712 Added 505.19%	152,992 $296,000
Q3 2023 Nov 14, 2023	SELL	$2.18 - $5.52 $1.25 Million - $3.15 Million	-571,523 Reduced 95.76%	25,280 $55,000
Q2 2023 Aug 14, 2023	BUY	$3.16 - $4.96 $1.76 Million - $2.76 Million	555,470 Added 1343.89%	596,803 $2.55 Million
Q1 2023 May 15, 2023	SELL	$3.6 - $5.88 $275,050 - $449,249	-76,403 Reduced 64.89%	41,333 $159,000

Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $339,585 - $579,252	67,512 Added 134.42%	117,736 $682,000
Q3 2022 Nov 14, 2022	BUY	$7.7 - $13.31 $386,724 - $668,481	50,224 New	50,224 $389,000
Q1 2022 May 16, 2022	BUY	$11.88 - $23.4 $746,848 - $1.47 Million	62,866 Added 137.15%	108,702 $1.66 Million
Q4 2021 Feb 14, 2022	BUY	$21.08 - $38.51 $836,686 - $1.53 Million	39,691 Added 645.91%	45,836 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$27.67 - $45.04 $1.39 Million - $2.26 Million	-50,119 Reduced 89.08%	6,145 $212,000
Q2 2021 Aug 16, 2021	SELL	$28.75 - $56.92 $4.06 Million - $8.05 Million	-141,343 Reduced 71.53%	56,264 $1.84 Million
Q4 2020 Feb 16, 2021	BUY	$55.23 - $81.11 $10.9 Million - $16 Million	197,607 New	197,607 $11.1 Million

Others Institutions Holding SEER

# of Institutions

Shares Held

42.9M

Call Options Held

200

Put Options Held

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $98.4M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account